Vertex Pharmaceuticals Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript
© -
Hi, everyone. My name is Evan Seigerman. I'm the senior large-cap biotechnology analyst here at Crédit Suisse. And it's my distinct pleasure to have Vertex Pharmaceuticals. And from Vertex, I have Reshma Kewalramani, that was a tough one, the current CMO, incoming CEO next year. And of course, Charlie Wagner, CFO; and also Michael Partridge from the IR team.
So thank you very much for coming to Scottsdale. My pleasure to have both of you here. And before we jump into Q&A, can you just give some high-level comments as to where Vertex is, highlighting the recent amazing progress?
Absolutely. Well, first of all, Evan, thanks for the invitation. Charlie and I are delighted to be here. For those of you joining on webcast, welcome to all of you as well. Maybe, Evan, let me just do some formalities and give you our safe harbor statement. We are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
